Stay updated on Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial page
- Check3 days agoChange DetectedThe page's revision label updated from v3.6.3 to v3.6.4, signaling a new version of the document. This change does not modify any study data or visible content.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, representing a minor version update to the page's metadata.SummaryDifference0.1%

- Check31 days agoChange DetectedA new 2026 publication citation was added to the Publications section. The previous 2025 online-ahead-of-print citation was replaced with updated bibliographic details.SummaryDifference0.1%

- Check45 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating the study is no longer enrolling. Additional changes include adding user-help sections (How to Read a Study Record, Common Questions, How to Join a Study), standardizing the Intervention header to 'Intervention/Treatment', and updating the page revision to v3.6.0.SummaryDifference0.4%

- Check52 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5. This indicates a minor update to the page's documentation or version history.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing Revision: v3.5.3. This indicates a small software or content-management update to the page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial page.